Horizon Pharma plc Has Commenced Solicitation of Depomed, Inc. Shareholders for Calling of Special...
Proposals to Be Considered Include Removal and Replacement of Entire Depomed Board of Directors and...
Lexicon Announces Sotagliflozin Data to be Presented at European Association for the Study of...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from its Phase 2 clinical study...
U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple...
If approved, daratumumab will offer a new option for double refractory, heavily pre-treated patients ...
Your Story, Your HIV Wisdom™ Brings Together HIV Voices and Supports HIV Community Organizations
Notable HIV Advocates Highlight Perspectives of People Living with or Affected by HIV to Leverage...
Johnson & Johnson Announces BARDA Funding Award to Accelerate Ebola Vaccine Program
Johnson & Johnson (NYSE: JNJ) announced today that Crucell Holland B.V., one of its Janssen...
Pivotal Phase II Study Showed Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in People with...
Genentech will discuss results with the U.S. Food and Drug Administration (FDA) as part of...
U.S. FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine ACE910 for People With...
First factor VIIIa-mimetic bispecific antibody to be investigated for the prophylactic treatment of hemophilia A...
New Directions in Breast Conserving Surgery – An Interview with Pat Whitworth, MD and...
Additionally, Frank Vicini, MD, Chief Academic Officer for Michigan Healthcare Professionals and 21st Century...
SABCS15: ONT-380 Phase I results support progression to Phase II in advanced HER2+ breast...
Phase I data regarding the experimental cancer agent ONT-380 were presented recently at the...
Early diagnosis of bowel cancer in the England – Report Highlights
The importance of national screening Data published by Cancer Research UK and Public Health England’s...
